An obesity medicine physician writes that weight-loss drugs such as Ozempic have been getting a bad rap, almost as if those ...
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...
In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
Women are increasingly turning to weight loss drugs like Wegovy and Mounjaro due to unrealistic beauty standards. Many use ...
And based on the data so far, amycretin looks even more impressive than Wegovy ... success, though, and amycretin's recent results highlight the fact that Novo Nordisk's weight loss pipeline ...
If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results